Clara Natoli

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

Medicine, Oncology, Pharmacology +17

Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.

Paola Patrignani, Maria R. Panara, Anita Greco et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 518 citations

Medicine, Pharmacology, Biochemical Pharmacology +13

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti et al. · Journal for ImmunoTherapy of Cancer · 2019 · 415 citations · Full text

Medicine, Immunology, Oncology +16

Concentrations of galectin-3 in the sera of normal controls and cancer patients.

Ida Iurisci, Nicola Tinari, Clara Natoli et al. · PubMed · 2000 · 290 citations

Medicine, Immunology, Oncology +11

Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties

Paola Matarrese, O. Fusco, Nicola Tinari et al. · International Journal of Cancer · 2000 · 235 citations

Life Sciences, Cell Biology, Oncology +17